| Quantification of differential transcription factor activity and multiomics-based classification into activators and repressors: diffTF I Berest, C Arnold, A Reyes-Palomares, G Palla, KD Rasmussen, H Giles, ... Cell Reports 29 (10), 3147-3159. e12, 2019 | 104 | 2019 |
| Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia J Lu, E Cannizzaro, F Meier-Abt, S Scheinost, PM Bruch, HAR Giles, ... Nature Cancer, 1-12, 2021 | 41 | 2021 |
| Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL PM Bruch, HAR Giles, C Kolb, SA Herbst, T Becirovic, T Roider, J Lu, ... Molecular Systems Biology 18 (8), e10855, 2022 | 11 | 2022 |
| Ex-Vivo Drug Response Profiling for Tailoring Treatment in Hematologic Malignancies: The Prospective Non-Interventional SMART-Trial N Liebers, PM Bruch, A Gambietz, H Giles, J Lu, M Knoll, C Kolb, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 5 | 2019 |
| Systematic Investigation of Microenvironmental Drug Resistance Mechanisms in Chronic Lymphocytic Leukemia PM Bruch, H Giles, C Kolb, S Rabe, T Roider, M Knoll, M Kriegsmann, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 2 | 2019 |
| Chronic Lymphocytic Leukaemia and the Tumour Microenvironment: A multi-omics investigation of interactions between genetic aberrations and external signals and their impact on … HAR Giles | | 2022 |
| Clinical implementation of an ex-vivo drug response profiling for hematologic malignancies: results of an interim analysis of the prospective non-interventional SMART trial N Liebers, PM Bruch, T Terzer, J Lu, H Giles, M Knoll, C Kolb, A Lenze, ... ONCOLOGY RESEARCH AND TREATMENT 43 (SUPPL 4), 248-249, 2020 | | 2020 |
| Drug cytokine interaction map in chronic lymphocytic leukemia PM Bruch, H Giles, C Kolb, S Rabe, T Roider, M Knoll, M Kriegsmann, ... ONCOLOGY RESEARCH AND TREATMENT 42, 221-221, 2019 | | 2019 |
Peter-Martin BruchUniversity Hospital DüsseldorfVerified email at med.uni-duesseldorf.de
